Aeovian获5500万美元融资,用于结节性硬化症研究,并探索肥胖症治疗前景。
Aeovian gets $55M for tuberous sclerosis complex, to explore prospects in obesity
生物技术与制药领域的最新动态
Aeovian gets $55M for tuberous sclerosis complex, to explore prospects in obesity
5 CDER directors in one year? Turnover threatens ‘institutional memory’ at US health agencies.
Onco3r Therapeutics divulges new TP53 stabilizers
Hangzhou Baicreat Pharma-Tech describes new PTPN1 and PTPN2 inhibitors
Aurora kinase B inhibitors disclosed in Nippon Shinyaku patent
Chinese scientists discover new C5aR antagonists
Other news to note for Dec. 16, 2025
RTW startup signs autoimmune antibody pact with China’s GenSci
FDA extends decision on Aldeyra's dry eye disease drug
Barclays Maintains 10x Genomics (TXG) Overweight Recommendation - Nasdaq
Waters Corporation $WAT Shares Sold by Armstrong Henry H Associates Inc. - MarketBeat
Aaron Wealth Advisors LLC Acquires 2,480 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Cell Free DNA Testing Market Is Going to Boom |• Illumina • Guardant Health - openPR.com
Sanofi signs $1B biobucks pact for Alzheimer’s asset in 2nd biotech deal of the day
Executive Q&A Video: SPT Labtech and 10x Genomics on Automating Single-Cell Workflows - GenomeWeb
Lifestyles shape genome size and gene content in fungal pathogens
Exploiting fluctuations in gene expression to detect causal interactions between genes
Immunoglobulin M regulates airway hyperresponsiveness independent of T helper 2 allergic inflammation
A systematic bi-genomic split-GFP assay illuminates the mitochondrial matrix proteome and protein targeting routes
Transcriptional subtypes on immune microenvironment and predicting postoperative recurrence and metastasis in human pheochromocytoma and paraganglioma